Identification of differentially expressed genes by meta-analysis of microarray data on breast cancer

In Silico Biology

Volumn 8, Issue 5-6, 2008, Pages 383-411

  Kondrakhin, Yury V ^a,b   Sharipov, Ruslan N ^a,b,c   Kel, Alexander E ^d   Kolpakov, Fedor A ^a,b  

^a Institute of Systems Biology   (Russian Federation)

^b Design Technological Institute of Digital Techniques of the Siberian Branch of the RAS   (Russian Federation)

^c INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^d BIOBASE GMBH   (Germany)

Author keywords

Breast cancer; cDNA microarray data; Cyclonet database; Differentially expressed genes; drug targets; hypergeometric distribution; Meta analysis

Indexed keywords

ALGORITHMS; BREAST NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC HETEROGENEITY; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 58149373932     PISSN: 13866338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ball, C. A., Awad, I. A., Demeter, J., Gollub, J., Hebert, J. M., Hernandez-Boussard, T., Jin, H., Matese, J. C., Nitzberg, M. and Wymore, F. (2005). The Stanford Microarray Database accommodates additional microarray platforms and data formats. Nucleic Acids Res. 33, D580-D582.
2. Barrett, T., Troup, D. B., Wilhite, S. E., Ledoux, P., Rudnev, D., Evangelista, C., Kim, I. F., Soboleva, A., Tomashevsky, M. and Edgar, R. (2007). NCBI GEO: Mining tens of millions of expression profiles - database and tools update. Nucleic Acids Res. 35, D760-D765.
3. Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289-300.
4. Efron, B. (2004). Large-scale simultaneous hypothesis testing: The choice of a null hypothesis. JASA 99, 96-104.
5. Finocchiaro, D. F., Mancuso, F. M., Cittaro, D. and Muller, H. (2007). Graph-based identification of cancer signaling pathways from published gene expression signatures using PubLiME. Nucleic Acids Res. 35, 2343-2355.
6. Grüzmann, R., Boriss, H., Ammerpohl, O., Lüttges, J., Kalthoff, H., Schackert, H. K., Klöppel, G., Saeger, H. D. and Pilarsky, C. (2005). Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene 24, 5079-5083.
7. Gruvberger, S., Ringner, M., Chen, Y., Panavally, S., Saal, L. H., Borg, A., Ferno, M., Peterson, C. and Meltzer, P. S. (2001). Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61, 5979-5984.
8. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Kallioniemi, O.-P., Wilfond, B., Borg, A. and Trent, J. (2001). Gene expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539-548.
9. Hoch, R. V., Thompson, D. A., Baker, R. J. and Weigel, R. J. (1999). GATA-3 is expressed in association with estrogen receptor in breast cancer. Int. J. Cancer. 84, 122-128.
10. Kolpakov, F., Poroikov, V., Sharipov, R., Kondrakhin, Y., Zakharov, A., Lagunin, A., Milanesi, L. and Kel, A. (2007). CYCLONET - an integrated database on cell cycle regulation and arcinogenesis. Nucleic Acids Res. 33, D562-D566.
11. Lacroix, M. and Leclercq, G. (2004). About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-α gene (ESR1) in breast cancer. Mol. Cell. Endocrinol. 219, 1-7.
12. Ma, X. J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., Zhou, Y. X., Varnholt, H., Smith, B., Gadd, M., Chatfield, E., Kessler, J., Baer, T. M., Erlander, M. G. and Sgroi, D. C. (2003). Gene expression profiles of human breast cancer progression. Proc. Natl. Acad. Sci. USA 100, 5974-5979.
13. Marine, J. and Winoto, A. (1991). The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements. Proc. Natl. Acad. Sci. USA 88, 7284-7288.
14. McLachlan, G. J., Bean, R. W., Ben-Tovim, J. L. and Zhu, J. X. (2005). Using mixture models to detect differentially expressed genes. Aust. J. Exp. Agric. 45, 859-866.
15. McLachlan, G. J., Bean, R. W. and Ben-Tovim, J. L. (2006). A simple implementation of a normal mixture approach to differential gene expression in multiclass microarrays. Bioinformatics 22, 1608-1615.
16. Mehra, R., Varambally, S., Ding, L., Shen, R., Sabel, M. S., Ghosh, D., Chinnaiyan, A. M. and Kleer, C. G. (2005). Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res. 65, 11259-11264.
17. Perelman, E., Ploner, A., Calza, S. and Pawitan,Y. (2007). Detecting differential expression in microarray data: Comparison of optimal procedures. BMC Bioinformatics 8, 28.
18. Perez-Stable, C. M., Pozas, A. and Roos, B. A. (2000). A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer. Mol. Cell. Endocrinol. 167 43-53.
19. Perou, C. M., Jeffrey, S. S., van de Rijn, M. Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C. F., Lashkari, D., Shalon, D., Brown, P. O. and Botstein, D. (1999). Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96, 9212-9217.
20. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Berresen-Dale, A. L., Brown, P. O. and Botstein, D. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
21. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A. and Chinnaiyan, A. M. (2004a). Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. USA 101, 9309-9314.
22. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A. and Chinnaiyan, A. M. (2004b). ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6.
23. Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Wolf, D. M. and Horwitz, K. B. (2002). Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277, 5209-5218.
24. Shen, R., Ghosh, D. and Chinnaiyan, A. M. (2004). Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data. BMC Genomics 5, 94.
25. Shen, D., Chang, H. R., Chen, Z., He, J., Lonsberry, V., Elshimali, Y., Chia, D., Seligson, D., Goodglick, L., Nelson, S. F. and Gornbein, J. A. (2005). Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem. Biophys. Res. Commun. 326 218-227.
26. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Lønning, P. E. and Børresen-Dale, A. L. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869-10874.
27. Sorlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., Demeter, J., Perou, C. M., Lonning, P. E., Brown, P. O., Borresen-Dale, A. L. and Botstein, D. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100 8418-8423.
28. Storey, J. D. and Tibshirany, R. (2003). Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440-9445.
29. Taylor, J., Tibshirani, R. and Efron, B. (2005). The 'miss rate' for the analysis of gene expression data. Biostatistics 6, 111-117.
30. Usary, J., Llaca, V., Karaca, G., Presswala, S., Karaca, M., He, X., Langerød, A., Kåresen, R., Oh, D. S., Dressler, L. G., Lønning, P. E., Strausberg, R. L., Chanock, S., Børresen-Dale, A. L. and Perou, C. M. (2004). Mutation of GATA3 in human breast tumors. Oncogene 23 7669-7678.
31. Van Esch, H., Groenen, P., Nesbit, M. A., Schuffenhauer, S., Lichtner, P., Vanderlinden, G., Harding, B., Beetz, R., Bilous, R. W., Holdaway, I., Shaw, N. J., Fryns, J. P., Van de Ven, W., Thakker, R. V. and Devriendt, K. (2000). GATA3 haplo-insufficiency causes human HDR syndrome. Nature 6794, 419-422.
32. Van't Veer, L. J., Dai, D., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M.J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R. and Friend, S. H. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.
33. Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., Jatkoe, T., Berns, E. M., Atkins, D. and Foekens, J. A. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679.
34. Zhao, H., Langerød, A., Ji, Y., Nowels, K. W., Nesland, J. M., Tibshirani, R., Bukholm, I. K., Kåreseljnnnn, R., Botstein, D., Borresen-Dale, A. L. and Jeffrey, S. S. (2004). Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell. 15, 2523-2536.
35. Zhu, J., Yamane, H., Cote-Sierra, J., Guo, L. and Paul, W. E. (2006). GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cellspecific factors. Cell Res. 16, 3-10.